Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Management of MRSA-positive eye swabs and the potential advantages of chloramphenicol availability in the United Kingdom.

× No keyword cloud information.

14 in total

1. Trends in antimicrobial drug development: implications for the future.

Authors: Brad Spellberg; John H Powers; Eric P Brass; Loren G Miller; John E Edwards
Journal: Clin Infect Dis Date: 2004-04-14 Impact factor: 9.079

2. Analysis of licensed over-the-counter (OTC) antibiotics in the European Union and Norway, 2012.

Authors: Leonard Both; Radu Botgros; Marco Cavaleri
Journal: Euro Surveill Date: 2015

3. Exposure to topical chloramphenicol during pregnancy and the risk of congenital malformations: a Danish nationwide cohort study.

Authors: Vilde Thomseth; Vanja Cejvanovic; Espen Jimenez-Solem; Kasper M Petersen; Henrik E Poulsen; Jon T Andersen
Journal: Acta Ophthalmol Date: 2015-04-28 Impact factor: 3.761

Review 4. Reviving old antibiotics.

Authors: Ursula Theuretzbacher; Françoise Van Bambeke; Rafael Cantón; Christian G Giske; Johan W Mouton; Roger L Nation; Mical Paul; John D Turnidge; Gunnar Kahlmeter
Journal: J Antimicrob Chemother Date: 2015-06-10 Impact factor: 5.790

5. Seeing red: over-the-counter chloramphenicol.

Authors: Dana Robaei; Mark Naunton; Stephanie Watson
Journal: Clin Exp Ophthalmol Date: 2015-03 Impact factor: 4.207

Review 6. What we may expect from novel antibacterial agents in the pipeline with respect to resistance and pharmacodynamic principles.

Authors: Karen Bush; Malcolm G P Page
Journal: J Pharmacokinet Pharmacodyn Date: 2017-02-04 Impact factor: 2.745

Review 7. The antibiotic pipeline for multi-drug resistant gram negative bacteria: what can we expect?

Authors: Matthew E Falagas; Andreas D Mavroudis; Konstantinos Z Vardakas
Journal: Expert Rev Anti Infect Ther Date: 2016-08 Impact factor: 5.091

8. Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001.

Authors: Scott K Fridkin; Jeff Hageman; Linda K McDougal; Jasmine Mohammed; William R Jarvis; Trish M Perl; Fred C Tenover
Journal: Clin Infect Dis Date: 2003-01-31 Impact factor: 9.079

9. Report of the 13th vancomycin-resistant Staphylococcus aureus isolate from the United States.

Authors: Brandi M Limbago; Alexander J Kallen; Wenming Zhu; Paula Eggers; Linda K McDougal; Valerie S Albrecht
Journal: J Clin Microbiol Date: 2013-12-26 Impact factor: 5.948

10. Vancomycin Ophthalmic Ointment 1% for methicillin-resistant Staphylococcus aureus or methicillin-resistant Staphylococcus epidermidis infections: a case series.

Authors: Chie Sotozono; Masahiko Fukuda; Masao Ohishi; Keiko Yano; Hideki Origasa; Yoshinori Saiki; Yoshikazu Shimomura; Shigeru Kinoshita
Journal: BMJ Open Date: 2013-01-29 Impact factor: 2.692